The website of Pathology In Practice Magazine

NEWS

Highlights of the National Comparative Audits of Blood Transfusion

Highlights of the National Comparative Audits of Blood Transfusion

A joint SHOT and NCA webinar will run on Tuesday 15 February 2022 (14:00–15:00 GMT).

The National Comparative Audit (NCA) of Blood Transfusion is the largest programme of clinical audits of blood transfusion in the world and is funded by NHS Blood and Transplant in England. Please join us for our webinar where the NCA team will present the findings from three National Comparative Audits and the SHOT team will provide insights from haemovigilance reporting:

• 2018 audit of the use of fresh frozen plasma, cryoprecipitate and transfusions for bleeding in neonates and older children – Dr Helen New

• 2019 Re-audit of the medical use of red cells – Dr Andrew Charlton

• 2021 audit of NICE Quality Standard 138 – Professor Mike Murphy and John Grant-Casey.

This one-hour webinar is free to access and will include:

A 40-minute presentation by experts from NCA and SHOT

A 20-minute interactive Q&A session.

An excellent opportunity for CPD through reflective practice, with the following learning objectives:

• Understand how to avoid unnecessary paediatric plasma transfusions

• Changing the way we use blood for greater patient benefit

• Discover how trusts are complying with the NICE Quality Standard

This webinar will be relevant to all healthcare professionals involved in transfusion – nursing staff, laboratory staff, clinicians, transfusion practitioners, clinical audit and effectiveness teams, quality managers, haemovigilance and risk management specialists

Click here to register.

The Zoom link to the live event is contained in the registration email.

You can also contact SHOT directly to register by email ([email protected]).

The event will commence promptly, so please join at least five minutes prior to the start.

FEATURES

IBMS Congress: delivering science, celebrating achievement

The delayed fourteenth iteration in the biennial Congress series will return to the International Convention Centre in Birmingham next March. Here, Pathology in Practice provides a brief preview of the four-day event.

Beyond LIS and LIMS: coordinated orders and results management

Extending laboratory reach beyond the hospital works best with the integration of specialised surrounding solutions. Here, in a moderated session, thought-leaders from Sunquest and CliniSys Group explore the benefits of purpose-built technology.

Human papillomavirus: current open-access research interest

Vaccination against human papillomavirus (HPV) infection has proved to reduce the incidence of cervical cancer by nearly 90%. Research into all aspects of HPV-related disease continues as the following examples illustrate.

Higher-specificity D-dimer scores in health technology assessment

Recent studies have supported a D-dimer assay role in ruling out venous thromboembolism and pulmonary embolism, linking it to health technology assessment savings, as Gillian Eyre explains.

PRODUCTS

LATEST ISSUEs

January 2022
December 2021
September 2020

Upcoming Events

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025